Patent intelligence · US
US 8603456
Method of treating hair loss with compositions containing interleukin-1
Method of treating hair loss with compositions containing interleukin-1
Patent details — US 8603456
- Jurisdiction
- US
- Status
- granted
- Grant date
- Dec 10, 2013
- Expiration
- Dec 5, 2033
- Applicant
- United Technologies UT AG
- Claims
- 4
- CPC classes
- A61K, A61K8/64
Quick answer
US 8603456 (Method of treating hair loss with compositions containing interleukin-1) is held by United Technologies UT AG. Status: granted. Granted Dec 10, 2013. Expires Dec 5, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- United Technologies UT AG
- Grant date
- Expiration
- Claims
- 4
- CPC classes
- A61K, A61K8/64
More from United Technologies UT AG
Related pharmaceutical patents in our USPTO index.
-
US 12419873
Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related diseases
granted -
US 12419941
Poultry drinking water-based vaccine delivery system and method
granted -
US 12415845
Methods of producing T cell populations using hydroxycitric acid and/or a salt thereof
granted -
US 12410240
Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection
granted -
US 12410259
CD47 targeted therapies for the treatment of infectious disease
granted -
US 12404317
T cell receptors recognizing MHC class II-restricted MAGE-A3
granted -
US 12397066
Delivery of gene therapy treatments
granted -
US 12398123
Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria
granted
Frequently asked questions
What is US patent 8603456?
US 8603456 (Method of treating hair loss with compositions containing interleukin-1) is held by United Technologies UT AG. Status: granted. Granted Dec 10, 2013. Expires Dec 5, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8603456?
United Technologies UT AG is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 3,720 pharmaceutical patents for this assignee.
When does US 8603456 expire?
Our index shows an expiration date of Dec 5, 2033 (7 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.